Global Blood Therapeutics, Inc. (GBT): Price and Financial Metrics
GBT Price/Volume Stats
| Current price | $68.49 | 52-week high | $73.02 |
| Prev. close | $68.48 | 52-week low | $21.65 |
| Day low | $68.47 | Volume | 3,279,900 |
| Day high | $68.49 | Avg. volume | 2,065,836 |
| 50-day MA | $62.32 | Dividend yield | N/A |
| 200-day MA | $38.21 | Market Cap | 4.62B |
GBT Stock Price Chart Interactive Chart >
Global Blood Therapeutics, Inc. (GBT) Company Bio
Global Blood Therapeutics is a clinical stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need. The company was founded in 2012 and is based in San Francisco, California.
GBT Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | 125.67% |
| 5-year | 22.00% |
| YTD | N/A |
| 2023 | N/A |
| 2022 | 0.00% |
| 2021 | -32.42% |
| 2020 | -45.52% |
| 2019 | 93.64% |
Loading social stream, please wait...